Share

EORTC PhD fellow Emma Willems addresses how do leaders of international non-profit organizations deal with resource pressures caused by the COVID-19 pandemic

Since 1991, the EORTC Fellowship Program enables physicians, statisticians and scientists from around the world to engage in clinical research that advances the EORTC’s evolving scientific strategy in the fight against cancer. Support for the EORTC Fellowship Programme comes from several sources, and more than 190 fellowships covering 35 countries have been awarded so far.

Emma L. Willems, a PhD fellow at EORTC funded by the EORTC’s Cancer Research Fund (ECRF), has co-authored an article that was recently published in the Journal of Contingencies and Crisis Management.

In their article, Emma L. Willems, Stijn Van Puyvelde, Marc Jegers and Peter Raeymaeckers overview the challenges experienced by international non-profits during the COVID-19 pandemic and investigate the responsive actions of the leadership (board of directors and managerial executive) to the health crisis. The results indicate resource decreases in nearly all stakeholder channels. In response, non-profit boards increased activity levels by mainly focusing on adapting organizational offerings and increasing support to the organization. Managerial executives also increased their activity levels, by focusing on safeguarding financial stability, planning and adapting operations to confinement measures.

You can read the full article here.

Back to news list

Related News

  • EORTC participation at ISPOR Europe 2025 conference

  • EORTC Quality of Life Group participating at the ISOQOL 2025 Conference

  • New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

  • EORTC celebrates the 100th anniversary of p-value on World Statistics Day

  • EORTC Announces Final Overall Survival Results from the PEACE-3 Trial

  • Results from EORTC trial define new standard of care for aggressive brain tumours

  • EORTC’s presence at ESMO 2025

  • EORTC’s presence at EANO 2025

  • EORTC celebrates Pink October: shaping the future of breast cancer care

  • EORTC shines a light on advancements in radioligand therapy